Showing results (31-40 of 377) with videos related to
Sort By:
Pageof 38
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 2, 2015
In Silico Analysis of NF2 Gene Missense Mutations in Neurofibromatosis Type 2: From Genotype to PhenotypeThomas E Heineman, D Gareth R Evans, Fabien Campagne, et al.Breast Cancer Research : BCR|November 13, 2004
Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogensAnthony Howell, Mitch DowsettCancer Treatment Reviews|October 4, 2005
Clinical development of fulvestrant ("Faslodex")Anthony Howell, Paul AbramThe Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Are aromatase inhibitors superior to antiestrogens?Anthony Howell, Aman BuzdarThe Journal of Steroid Biochemistry and Molecular Biology|June 7, 2005
Vascular effects of aromatase inhibitors: data from clinical trialsAnthony Howell, Jack CuzickExpert Review of Anticancer Therapy|July 13, 2002
Fulvestrant (Faslodex): current status in the therapy of breast cancerNigel Bundred, Anthony HowellThe Proceedings of the Nutrition Society|March 15, 2012
Energy restriction and the prevention of breast cancerMichelle Harvie, Anthony HowellClinical Breast Cancer|July 7, 2011
Fulvestrant revisited: efficacy and safety of the 500-mg doseAnthony Howell, Francisco SapunarEuropean Journal of Human Genetics : EJHG|April 16, 2009
Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary riskD Gareth R Evans, Richard Clayton, Paul Donnai, et al.British Journal of Cancer|September 13, 2022
A mechanistic mathematical model of initiation and malignant transformation in sporadic vestibular schwannomaChay Paterson, Ivana Bozic, Miriam J Smith, et al.Pageof 38